These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 34319246
1. Turn on, Tune in, and Drop out: Predictors of Attrition in a Prospective Observational Cohort Study on Psychedelic Use. Hübner S, Haijen E, Kaelen M, Carhart-Harris RL, Kettner H. J Med Internet Res; 2021 Jul 28; 23(7):e25973. PubMed ID: 34319246 [Abstract] [Full Text] [Related]
2. Effects of Psychedelics in Older Adults: A Prospective Cohort Study. Kettner H, Roseman L, Gazzaley A, Carhart-Harris RL, Pasquini L. Am J Geriatr Psychiatry; 2024 Sep 28; 32(9):1047-1059. PubMed ID: 38849218 [Abstract] [Full Text] [Related]
3. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample. Nygart VA, Pommerencke LM, Haijen E, Kettner H, Kaelen M, Mortensen EL, Nutt DJ, Carhart-Harris RL, Erritzoe D. J Psychopharmacol; 2022 Aug 28; 36(8):932-942. PubMed ID: 35924888 [Abstract] [Full Text] [Related]
4. Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample. Mans K, Kettner H, Erritzoe D, Haijen ECHM, Kaelen M, Carhart-Harris RL. Front Psychiatry; 2021 Aug 28; 12():647909. PubMed ID: 34267683 [Abstract] [Full Text] [Related]
6. The Psychedelic Personality: Personality Structure and Associations in a Sample of Psychedelics Users. Johnstad PG. J Psychoactive Drugs; 2021 Aug 28; 53(2):97-103. PubMed ID: 33252034 [Abstract] [Full Text] [Related]
11. Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness. Kettner H, Rosas FE, Timmermann C, Kärtner L, Carhart-Harris RL, Roseman L. Front Pharmacol; 2021 Aug 28; 12():623985. PubMed ID: 33995022 [Abstract] [Full Text] [Related]
12. Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting. Argento E, Strathdee SA, Tupper K, Braschel M, Wood E, Shannon K. BMJ Open; 2017 Sep 21; 7(9):e016025. PubMed ID: 28939573 [Abstract] [Full Text] [Related]
15. Cessation and reduction in alcohol consumption and misuse after psychedelic use. Garcia-Romeu A, Davis AK, Erowid F, Erowid E, Griffiths RR, Johnson MW. J Psychopharmacol; 2019 Sep 21; 33(9):1088-1101. PubMed ID: 31084460 [Abstract] [Full Text] [Related]
18. Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory. Roseman L, Haijen E, Idialu-Ikato K, Kaelen M, Watts R, Carhart-Harris R. J Psychopharmacol; 2019 Sep 21; 33(9):1076-1087. PubMed ID: 31294673 [Abstract] [Full Text] [Related]
19. Positive effects of psychedelics on depression and wellbeing scores in individuals reporting an eating disorder. Spriggs MJ, Kettner H, Carhart-Harris RL. Eat Weight Disord; 2021 May 21; 26(4):1265-1270. PubMed ID: 32895801 [Abstract] [Full Text] [Related]
20. The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women. Argento E, Braschel M, Walsh Z, Socias ME, Shannon K. J Psychopharmacol; 2018 Dec 21; 32(12):1385-1391. PubMed ID: 30255717 [Abstract] [Full Text] [Related] Page: [Next] [New Search]